Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-27

Clinical Trial Update: A Safety and Efficacy Study of BOTOX® in Korean Adults With Chronic Migraine [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety and efficacy of BOTOX in Korean adults with chronic migraine. Results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Migraine Disorders | Phase 4 | Status: COMPLETED | Results posted: 2016-05-27